Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

Clinical trial NCT04526886 · COMPLETED

Trial details

NCT number: NCT04526886
Sponsor: Dartmouth-Hitchcock Medical Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Colorectal Cancer Gastric Cancer Esophageal Cancer Ampullary Cancer Small Bowel Cancer Appendix Cancer

Start date: 2020-10-15
Primary completion: 2023-03-07
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.